A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Public ClinicalTrials.gov record NCT02564198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study Of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children With Refractory Solid Tumors, Including CNS Tumors
Study identification
- NCT ID
- NCT02564198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 29 participants
Conditions and interventions
Interventions
- Ramucirumab Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Months to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 10, 2015
- Primary completion
- Jul 15, 2019
- Completion
- Jul 15, 2019
- Last update posted
- Aug 16, 2021
2015 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital of Alabama | Birmingham | Alabama | 35233 | — |
| Children's Oncology Group | Monrovia | California | 91016 | — |
| Childrens Hospital of Orange County | Orange | California | 92868 | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010-2970 | — |
| Children's Healthcare of Atlanta at Scottish Rite | Atlanta | Georgia | 30322 | — |
| Ann & Robert H Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| Mark O Harfield-Warren Grant Magnuson Clinical Center | Bethesda | Maryland | 20892 | — |
| University of Michigan Health Systems | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota Hospital | Minneapolis | Minnesota | 55455 | — |
| Washington University Medical School | St Louis | Missouri | 63110 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Children's Hospital Medical Center | Cincinnati | Ohio | 45229-3039 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Childrens Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | — |
| St Jude Childrens Research Hospital | Memphis | Tennessee | 38105 | — |
| Texas Childrens Hospital | Houston | Texas | 77030 | — |
| Seattle Children's Hospital Research Foundation | Seattle | Washington | 98105 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02564198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2021 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02564198 live on ClinicalTrials.gov.